Vectura Group Share Price (VEC)

179.70 +1.20 (+0.67%) delayed: 4:13AM BST
Bid price 178.90 Open price 180.00
Ask price 180.50 Prev close 179.50
High price 180.00 Spread 0.89%
Low price 177.20 Volume 122,424

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 179.70 Net Gearing (%) -6.27
Market Capitalisation (£m) 722.06 Gross Gearing (%) 24.40
Shares in issue (m) 404.52 Debt Ratio 10.20
P/E Ratio 198.33 Debt-to-Equity Ratio 0.35
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.32
Dividend Yield (%) 0.00 Price to book value 3.25
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) 0.90 EPS Growth (%) 228.57
52 week high / low 183.75 / 113.75 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
07/07/2015 BUY Dr Trevor Phillips ED 1,000
07/07/2015 BUY Andrew Oakley FD 1,000
17/04/2015 EXR Dr Christopher Blackwell RES 18,987
16/01/2015 EXR Dr Trevor Phillips ED 3,133
16/01/2015 EXR Dr Trevor Phillips ED 208,877

More Vectura Group Director Deals >>

Vectura Group Company News

07:00 28/07/2015

Pre-IND meeting with the US FDA regarding VR647

/* */ RNS Number : 2326U Vectura Group plc 28 July 2015     Vectura Group plc   Announces successful pre-IND meeting with the US FDA regarding VR647     Chippenham, UK - 28 July 2015: Vectura Group plc (LSE: VEC; "Vectura"...

09:29 15/07/2015

Free Shares Award

/* */ RNS Number : 1034T Vectura Group plc 15 July 2015   Annex DTR3   Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons     All relevant boxes should be completed in block...

14:45 07/07/2015

Director Deals - Vectura Group PLC (VEC)

Andrew Oakley, Financial Director, bought 1,000 shares in the company on the 6th July 2015 at a price of 180.00p. The Director now holds 1,000 shares representing 0.00% of the shares in issue. NOTE: SIP Purchase: Also awarded 1000 matching shares Story provided by Director...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

4 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions